Profiles for generic drugs starting with 'x'
✉ Email this page to a colleague
US Patents and Regulatory Information for x
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mallinckrodt | XENEISOL | xenon xe-133 | SOLUTION;INHALATION, INJECTION | 017262-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Polarean | XENOVIEW | xenon xe-129 hyperpolarized | GAS;INHALATION | 214375-001 | Dec 23, 2022 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Mallinckrodt | XENON XE 127 | xenon xe-127 | GAS;INHALATION | 018536-002 | Oct 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
